Community Schedule

Enter at least 4 characters

1 results showing for: 'emtricitabine with tenofovir disoproxil'

Emtricitabine with tenofovir disoproxil    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 112.
- Subsidy by endorsement ; can be waived by Special Authority SA1994
  • Tab 200 mg with tenofovir disoproxil 245 mg (300.6 mg as a succinate)
    • Brand Fully subsidised brand. Teva
    • Pharmacode2560488
    • Subsidy $61.15
    • Measure / Qty per 30
SA1994 - Emtricitabine with tenofovir disoproxil

Endorsement for treatment of HIV: Prescription is deemed to be endorsed if emtricitabine with tenofovir disoproxil is co-prescribed with another antiretroviral subsidised under Special Authority SA1651 and the prescription is annotated accordingly by the Pharmacist or endorsed by the prescriber.


Emtricitabine with tenofovir disoproxil prescribed under endorsement for the treatment of HIV is included in the count of up to 4 subsidised antiretrovirals, and counts as two antiretroviral medications, for the purposes of Special Authority SA1651, page 1

There is an approval process to become a named specialist to prescribe antiretroviral therapy in New Zealand. Further information is available on the Pharmac website.

For eye preparations refer to Eye Preparations, Anti-Infective Preparations, page 259

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply